Unlocking future medicines: The crucial role of clinical trials
Regeneron’s clinical trials are at the core of this mission. Regeneron is grateful to all clinical trial participants — ...
Positive Outlook for Mereo Biopharma Group Plc Amidst Promising Therapeutic Developments and Strong Financial Position
Analyst Jack Allen from Robert W. Baird maintained a Buy rating on Mereo Biopharma Group Plc (MREO – Research Report) and keeping the ...
Cautious Hold Rating on Fulcrum Therapeutics Amid Uncertain Prospects and Strategic Shifts
Andrew Fein, an analyst from H.C. Wainwright, reiterated the Hold rating on Fulcrum Therapeutics (FULC – Research Report). The associated ...
NOLA.com3h
LSU researchers develop handheld device to detect cancer cells during surgery. Here’s how it works.
A new device out of LSU can detect where cancer cells end and healthy tissues begin. Here's what it means for health outcomes ...
Presbyopia Treatment Market Set To Reach New Heights With New Therapies And Advancements By 2034 Delveinsight
The launch of emerging therapies, such as LNZ100 by Lenz Therapeutics, Phentolamine Ophthalmic Solution 0.75% by Viatris an ...
bodyandsoul.com.au9h
men PMS hormones
Women have been speaking about pre-menstrual syndrome from decades, but could men be experiencing the same cycle? We asked ...
Kaleido Scope21h
Adult ADHD diagnoses soared during the pandemic. This expert says it is still undertreated.
About half of the estimated 15.5 million American adults who have ADHD were diagnosed during adulthood. UAB’s Rachel Fargason ...
S.F. hospital uses cutting-edge AI tool to help doctors identify stroke risks earlier
Doctors at Zuckerberg San Francisco General Hospital are using a cutting-edge AI tool to analyze medical scans, helping them ...
Port City Daily19h
Wilmington to become key player in life sciences, ILM a ‘global gateway’ in $1.5B project
The Wilmington International Airport and Frontier Scientific Solutions announced a new project utilizing the first free trade ...
Vivos Therapeutics, Inc. (VVOS) Q3 2024 Earnings Call Transcript
Vivos Therapeutics, Inc. ( NASDAQ: VVOS) Q3 2024 Earnings Conference Call November 14, 2024 5:00 PM ET Kirk Huntsman - Chariman & CEO Brad Amman - CFO Scott Henry - Alliance Global Partners Lucas Ward ...